CME Sam Continuing Medical Education and Self Assessment Modules

Continuing Medical Education and Self Assessment Modules: Meetings, Webinars, and Self Study Courses

Opioid Conference: Evidence, Clinical Considerations & Best Practice 2019
Thursday, November 7, 2019 - Saturday, November 9, 2019

CME Provider:
Mayo School of Continuous Professional Development ›
Kris Jones
200 First Street, SW
Rochester, Minnesota (MN) 55905
United States

Phone: (800) 323-2688

Visit the CME Provider Webpage ›

Conference Center:
The Ritz-Carlton Rancho Mirage ›
68900 Frank Sinatra Drive
Rancho Mirage, California (CA) 92270
United States

Phone: (760) 321-8282

Visit the Conference Center Webpage ›

Description:
The Mayo Clinic Opioid Conference: Evidence, Clinical Considerations & Best Practice 2019 aims to highlight the shift in guidelines and public concern regarding the use of opioids in medical practice and provides the most up-to-date information regarding the appropriate indication for opioids in clinical practice. Topics cover the basics of opioids, evidence-based guidelines for opioids, medication monitoring, tapering and legal considerations. In addition, the course covers a broad range of issues, including opioid addiction and difficult patient conversations and guidelines to standardize the practice of opioid prescribing.

Visit the CME Course Webpage ›

Instructors:
Halena M. Gazelka, M.D., and Nafisseh S. Warner, M.D.

CME Credit:
Physicians: Credit Available

Self Assessment Module (SAM): No

Specialty Audience:
Anesthesiology Emergency Medicine Family Medicine Internal Medicine Neurology Obstetrics / Gynecology Otolaryngology Pediatrics Surgery

CME Sam Course #22541

Map of The Ritz-Carlton Rancho Mirage, 68900 Frank Sinatra Drive, Rancho Mirage, California (CA), United States

Show Nearby: Rank By:

Healthcare Professionals CME Providers Advertise About Us

Terms of Use Privacy Policy

Copyright © 2013 Maxwell Publishing Company. All rights reserved.
The CME Sam logo and 'What's News In CME' are registered U.S. trademarks.

Follow Us